Vaccines and auto-vaccines to protect your health
At the forefront of research, development and marketing of immunotherapy treatments and natural food supplements for a healthier life.

Since 1995
We are leading innovators in immunotherapy, developing products that are designed to improve people's quality of life.
Our products
We develop innovative solutions to improve people's health and well-being. Our products range from immunotherapy treatments for allergies and infectious diseases to therapeutic nutritional supplements backed by over a decade of research. Science, technology and clinical experience combined to deliver effective and safe products that meet the needs of each patient.
Allergen immunotherapy
Immunotherapy treatment for allergies is based on allergen vaccination, also known as allergen-specific immunotherapy.
Bacterial immunotherapy
Bacterial immunotherapy is indicated for recurrent bacterial infectious and/or inflammatory conditions or for patients who respond poorly to conventional antibiotic treatment.
Therapeutic nutrition
The result of over 10 years of research in therapeutic nutrition, using the most cutting-edge technology and working with a multidisciplinary team of experts.
Patients
Our immunotherapy treatments are designed to strengthen your immune system and improve your day-to-day well-being. We want you to enjoy every moment with good health and peace of mind.


Work with us
At Probelte Pharma we believe that talent and passion make the difference. We offer an innovative, collaborative working environment that is constantly growing. If you want to be part of a team that is harnessing science to transform healthcare, this is the place for you.
Space for professionals
We provide healthcare professionals with scientific information, up-to-date resources and tools to support their clinical practice. We are committed to delivering evidence-based solutions. We want to support you in improving the health and well-being of patients.
News anddevelopment
Probelte Pharma SL was awarded a grant from the Murcia Regional Development Agency’s grant programme to encourage SMEs in the region to procure innovation and competitiveness services, co-funded by the European Regional Development Fund. File: 2024.08.hino.000112
The aim of this project was to promote a more efficient business environment, helping to deliver the benefits of tax credits to support business…
Probelte Pharma published the protocol for the PROACAROS phase III Beltavac® clinical trial in the TRIALS journal
Murcia, Spain — May 2025 Probelte Pharma has announced that the full protocol for the PROACAROS phase III clinical trial, designed to evaluate the…
Publication of findings on subcutaneous immunotherapy in the paediatric population
On 12 June, a study on the Beltavac® preparation was published in the Journal of Clinical Medicine, demonstrating the efficacy and good safety…
"Internationalisation Mentoring and Support” Programme
Probelte Pharma SLU, has received funding from the SME Internationalisation Mentoring and Support Programme. Among other costs, the company has used…
Probelte Pharma awarded the Plimsoll Certificate of Business Excellence 2023
Probelte Pharma SL, a manufacturer of allergen and bacterial immunotherapy products, has been awarded the Plimsoll Certificate of Business Excellence…

